Trigano C, Afchain F, Florent V, Bonnet A
Service de chirurgie plastique, centre hospitalier d'Arras, 3, boulevard Georges-Besnier, 62000 Arras, France.
Service de chirurgie plastique, centre hospitalier d'Arras, 3, boulevard Georges-Besnier, 62000 Arras, France.
Ann Chir Plast Esthet. 2022 Mar;67(2):68-72. doi: 10.1016/j.anplas.2022.03.002. Epub 2022 Apr 19.
The generalization of bariatric surgery interventions has led in recent years to an explosion in demand for body contouring surgeries. These operations can be followed by postoperative complications; and residual obesity, defined by a BMI≥30, is traditionally considered as a relative contraindication. The objective is to study the influence of a BMI≥30 on the risk of postoperative complications.
A retrospective study was conducted on all patients who underwent body contouring surgery between 2014 and 2020 at the Arras Hospital Center. Major complication rates were compared in obese and non-obese patients.
Two hundred twenty-three patients were included, representing a total of 247 surgeries: 124 in the BMI<30 group and 123 in the BMI≥30 group. Sixteen surgeries were followed by at least one major complication, 6 in group I versus 10 in group II (RR=1.7 (0.6-4.5), NS, P=0.29). Therefore there were not significantly more major complications in obese patients.
The incidence of major complications following body contouring surgeries is not modified by the presence of a BMI greater than 30, subject to a precautionary procedure adapted to each patient. BMI is therefore not a sufficient criterion to contraindicate this type of surgery.
近年来,减肥手术干预措施的普及导致身体塑形手术的需求激增。这些手术可能会引发术后并发症;传统上,体重指数(BMI)≥30所定义的残余肥胖被视为相对禁忌症。目的是研究BMI≥30对术后并发症风险的影响。
对2014年至2020年期间在阿拉斯医院中心接受身体塑形手术的所有患者进行了一项回顾性研究。比较了肥胖和非肥胖患者的主要并发症发生率。
纳入了223例患者,共进行了247例手术:BMI<30组124例,BMI≥30组123例。16例手术出现了至少一种主要并发症,第一组6例,第二组10例(相对危险度=1.7(0.6 - 4.5),无统计学意义,P = 0.29)。因此,肥胖患者的主要并发症并没有显著增多。
在采取适合每位患者的预防措施的情况下,BMI大于30并不会改变身体塑形手术后主要并发症的发生率。因此,BMI并不是禁止这类手术的充分标准。